Track topics on Twitter Track topics that are important to you
Bactevo will use its TIME platform to identify small molecule lead compounds
Bactevo has announced a drug discovery collaboration with Boehringer Ingelheim, with the aim of identifying new small molecule lead compounds....Read More... The post Bactevo and Boehringer Ingelheim ...
Bactevo Ltd. entered into a drug discovery collaboration with Boehringer Ingelheim GMBH to identify small-molecule compounds.
Bactevo Ltd. announced today that it has entered into a drug discovery collaboration agreement with Boehringer Ingelheim to identify novel small molecule lead compounds. This coll...
Bactevo, a UK tech firm with a focus on drug discovery, has announced a collaboration with privately-held…
Bactevo has built a unique and game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Utilising its paradigm shift in the speed, efficiency and qua...
Bactevo has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advance machine learning, TIME utilises its paradigm ...
We have published hundreds of Bactevo Ltd. news stories on BioPortfolio along with dozens of Bactevo Ltd. Clinical Trials and PubMed Articles about Bactevo Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bactevo Ltd. Companies in our database. You can also find out about relevant Bactevo Ltd. Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...